...
首页> 外文期刊>International Journal of Cardiology >Initial Q waves and outcome after reperfusion therapy in patients with ST elevation acute myocardial infarction: a systematic review.
【24h】

Initial Q waves and outcome after reperfusion therapy in patients with ST elevation acute myocardial infarction: a systematic review.

机译:ST抬高急性心肌梗死患者再灌注治疗后的初始Q波和预后:系统评价。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Patients with ST elevation acute myocardial infarction (STEMI) have different outcome depending on the reperfusion strategy. METHODS: To discern if the presence of initial Q waves in the infarct leads is a useful prognostic parameter in STEMI patients within 6 h of symptom onset treated by different reperfusion strategies (fibrinolysis, fibrinolysis followed by percutaneous coronary intervention [PCI], and primary PCI) we performed a systematic review on outcome comparing patients with and without initial Q waves. RESULTS: The relative risks for those with Q waves were significantly raised for both mortality and the composite outcome of mortality, congestive heart failure or cardiogenic shock, and at both 30-day and 90-day time points. The relative risk for mortality varied from 2.18 (95% CI 1.32-3.61) at 30 days to 2.54 (95% CI 1.87-3.44) at 90 days. The relative risk for composite outcome was 2.28 (95% CI 1.71-3.04) at 30 days and 2.25 (95% CI 1.81-2.80) at 90 days. CONCLUSION: The presence of initial Q waves is a relatively robust parameter to stratify outcome regardless of the reperfusion methods.
机译:背景:ST抬高急性心肌梗死(STEMI)患者根据再灌注策略具有不同的预后。方法:通过不同的再灌注策略(纤维蛋白溶解,纤维蛋白溶解然后经皮冠状动脉介入治疗[PCI]和原发性PCI),在梗塞导线中发现初始Q波是否对症状发作后6小时内的STEMI患者有有用的预后参数),我们对有无初始Q波的患者的结局进行了系统评价。结果:在30天和90天的时间点,Q波患者的死亡率和死亡率,充血性心力衰竭或心源性休克的综合结果均显着升高。死亡的相对风险从30天时的2.18(95%CI 1.32-3.61)到90天时的2.54(95%CI 1.87-3.44)不等。复合结果的相对风险在30天时为2.28(95%CI 1.71-3.04),在90天时为2.25(95%CI 1.81-2.80)。结论:无论再灌注方法如何,初始Q波的存在都是一个相对可靠的参数,可用于分层结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号